Hover over the bar plot to get the GO term. Differentially targeted genes and TFs were computed by comparing a cancer network to all other cancers.
Tool description
PANDA reconstructs a gene regulatory network using TF PPI, TF DNA binding motif, and gene expression samples. You can check the phenotypic information for the clinical variables of the samples that were used to reconstruct the network.
| # | Tissue | Tool | netZoo release | Network |
PPI |
Motif | Expression | Regulator | nReg | Genes | Data | Samples | Precision |
Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Cholangiocarcinoma | PANDA | netZooR 0.9 | TF | 644 | 29375 | TCGA | 36 | D |
Variable description
This is a description of the primary clinical variables of the gene expression samples that were used to generate the gene regulatory network.
| Sample |
Gender | Race | Stage |
Vital status | Age |
Days to last follow up | Tumor ID |
|---|---|---|---|---|---|---|---|
| TCGA-W5-AA36-01A | FEMALE | WHITE | Stage IV | Dead | - | [Not Available] | CHOL |
| TCGA-W5-AA2H-01A | FEMALE | WHITE | Stage III | Alive | - | 635 | CHOL |
| TCGA-WD-A7RX-01A | FEMALE | WHITE | Stage II | Dead | - | [Not Available] | CHOL |
| TCGA-3X-AAVC-01A | FEMALE | WHITE | Stage I | Alive | - | 371 | CHOL |
| TCGA-3X-AAVE-01A | MALE | ASIAN | Stage II | Alive | - | 203 | CHOL |
| TCGA-ZH-A8Y4-01A | MALE | WHITE | Stage I | Dead | - | [Not Available] | CHOL |
| TCGA-W5-AA2W-01A | FEMALE | WHITE | Stage IVA | Dead | - | [Not Available] | CHOL |
| TCGA-W5-AA2G-01A | FEMALE | WHITE | Stage I | Alive | - | 1976 | CHOL |
| TCGA-3X-AAVA-01A | FEMALE | WHITE | Stage II | Dead | - | [Not Available] | CHOL |
| TCGA-W5-AA2X-01A | MALE | WHITE | Stage IVB | Dead | - | [Not Available] | CHOL |
| TCGA-W5-AA2U-01A | FEMALE | WHITE | Stage I | Dead | - | [Not Available] | CHOL |
| TCGA-ZH-A8Y1-01A | FEMALE | WHITE | Stage IVA | Dead | - | [Not Available] | CHOL |
| TCGA-ZH-A8Y2-01A | FEMALE | BLACK OR AFRICAN AMERICAN | Stage I | Dead | - | [Not Available] | CHOL |
| TCGA-W5-AA30-01A | MALE | WHITE | Stage I | Alive | - | 1079 | CHOL |
| TCGA-W5-AA2T-01A | FEMALE | WHITE | Stage II | Dead | - | [Not Available] | CHOL |
| TCGA-3X-AAVB-01A | FEMALE | WHITE | Stage IVB | Alive | - | 368 | CHOL |
| TCGA-4G-AAZT-01A | MALE | WHITE | Stage I | Alive | - | 206 | CHOL |
| TCGA-W5-AA39-01A | MALE | WHITE | Stage II | Dead | - | [Not Available] | CHOL |
| TCGA-ZH-A8Y5-01A | MALE | WHITE | Stage IVB | Alive | - | 707 | CHOL |
| TCGA-W5-AA2Z-01A | FEMALE | WHITE | Stage II | Alive | - | 155 | CHOL |
| TCGA-ZU-A8S4-01A | MALE | WHITE | Stage I | Dead | - | [Not Available] | CHOL |
| TCGA-3X-AAV9-01A | MALE | ASIAN | Stage I | Dead | - | [Not Available] | CHOL |
| TCGA-ZH-A8Y8-01A | MALE | WHITE | Stage I | Alive | - | 104 | CHOL |
| TCGA-W5-AA2R-01A | FEMALE | WHITE | Stage I | Alive | - | 1485 | CHOL |
| TCGA-W5-AA31-01A | MALE | WHITE | Stage I | Alive | - | 10 | CHOL |
| TCGA-W5-AA2Q-01A | MALE | WHITE | Stage II | Alive | - | 50 | CHOL |
| TCGA-W5-AA38-01A | FEMALE | WHITE | Stage I | Alive | - | 964 | CHOL |
| TCGA-4G-AAZO-01A | FEMALE | WHITE | Stage II | Alive | - | 609 | CHOL |
| TCGA-ZD-A8I3-01A | FEMALE | ASIAN | Stage II | Alive | - | 0 | CHOL |
| TCGA-W5-AA2O-01A | MALE | WHITE | Stage I | Dead | - | [Not Available] | CHOL |
| TCGA-ZH-A8Y6-01A | FEMALE | BLACK OR AFRICAN AMERICAN | Stage I | Alive | - | 115 | CHOL |
| TCGA-W6-AA0S-01A | FEMALE | WHITE | Stage I | Alive | - | 352 | CHOL |
| TCGA-W5-AA33-01A | MALE | WHITE | Stage I | Alive | - | 1070 | CHOL |
| TCGA-YR-A95A-01A | MALE | WHITE | Stage IV | Dead | - | [Not Available] | CHOL |
| TCGA-W5-AA2I-01A | MALE | WHITE | Stage I | Dead | - | [Not Available] | CHOL |
| TCGA-W5-AA34-01A | FEMALE | WHITE | Stage I | Alive | - | 168 | CHOL |
| Sample | Gender | Race | Stage | Status | Age | Days to follow up | Tumor ID |